Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis

Abstract

Summary This study was performed to determine whether or not IL-18, formerly called IFN-γ-inducing factor, is involved in the pathogeneses of allergic disorders. Peripheral blood mononuclear cells (PBMC) were obtained from patients with allergic bronchial asthma (BA), patients with atopic dermatitis (AD) and controls who did not have any allergic disease, and then cultured with lipopolysaccharide (LPS) or phytohaemagglutinin (PHA). The concentrations of IL-18, IFN-γ and IL-13 in supernatant fluids were determined by enzymatic immunoassaying, and the expression of IFN-γ messenger (m) RNA in the cells was measured by colorimetric microplate assaying. IL-18 secretion in the BA patients (geometric mean (gm) = 189 pg/ml) and AD patients (gm = 172 pg/ml) was significantly higher than that in non-allergic controls (gm = 118 pg/ml). In contrast, IFN-γ secretion in the BA patients (gm = 7·3 IU/ml) and AD patients (gm = 6·8 IU/ml) was significantly lower than that in non-allergic controls (gm = 20·7 IU/ml). The amounts of IL-13 in supernatant fluids and IFN-γ mRNA in cells were not statistically different among the BA patients, AD patients and non-allergic controls. The possible involvement of IL-18 in allergic disorders is discussed.